Bristol Myers interested in buying Aurinia Pharma - Bloomberg News

Redirecting to full article in 5 second(s)...

Bristol Myers Squibb Co has expressed interest in buying autoimmune disease drug developer Aurinia Pharmaceuticals Inc , Bloomberg News reported on Friday, citing people familiar with the matter.